Study sheds light on progress and gaps in hepatitis C clearance cascade

FHS
July 4, 2023
8:41 am

Researchers described the hepatitis C virus (HCV) elimination cascade during the direct-acting antivirals (DAA) era.

Womb pressure shapes facial features, UCL study reveals

Physical cues in the womb, and not just genetics, influence the normal development of neural crest cells, the embryonic stem cells that form facial features,

April 23, 2024

Two drugs look promising for lipoprotein(a), a common genetic risk factor for heart disease

CHICAGO — Lipoprotein(a) is a risk factor for cardiovascular disease you may not hear about in your annual physical. Like LDL, or “bad” cholesterol, too

November 18, 2024

Gilead’s chief medical officer to leave as R&D efforts stall

Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of growth beyond its core

July 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.